Delivery Order SPE2DR25D2010-SPE2DR26F4ZNL
Award Date 1/6/26
Potential Completion Date 1/28/26
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 100 mg capsules (21-count). This is a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count units) on September 18, 2025, with completion scheduled for October 9, 2025. This competitively awarded, firm fixed-price contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) with a ceiling value of $8,559.84. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by January 21, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,244.96 by the Defense Logistics Agency on September 17, 2025, for the supply of Ibrance 100 mg capsules (21-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. Performance will be completed at the contractor's Conshohocken facility by October 8, 2025. This delivery...
- The Defense Logistics Agency awarded a $17,110.42 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 125 mg capsules (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of January 21, 2026, and performance being fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $8,559.84 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ibrance 100 mg capsules (21-count). This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of January 8, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,555.21 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count packages) on November 26, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order is unclassified as a set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on August 29, 2025, with completion expected by September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,559.84 on December 4, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) under a firm fixed-price contract. The award was made on a competitive basis with no set-aside designation. Performance will be executed from the company's Conshohocken, Pennsylvania location, with an ultimate completion date of December 26, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $8,122.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count packaging) on October 16, 2025, with an ultimate completion date of November 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...